U.S. flag

An official website of the United States government

NM_000102.3(CYP17A1):c.1084C>T (p.Arg362Cys) AND Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Apr 19, 2013
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000001869.1

Allele description

NM_000102.3(CYP17A1):c.1084C>T (p.Arg362Cys)

Gene:
CYP17A1:cytochrome P450, family 17, subfamily A, polypeptide 1 [Gene - OMIM]
Variant type:
single nucleotide variant
Cytogenetic location:
10q24.32
Genomic location:
Preferred name:
NM_000102.3(CYP17A1):c.1084C>T (p.Arg362Cys)
HGVS:
  • NC_000010.11:g.102832566G>A
  • NG_007955.1:g.9968C>T
  • NM_000102.3:c.1084C>T
  • NP_000093.1:p.Arg362Cys
  • NC_000010.10:g.104592323G>A
Protein change:
R362C; ARG362CYS
Links:
OMIM: 609300.0023; dbSNP: rs104894142
NCBI 1000 Genomes Browser:
rs104894142
Molecular consequence:
  • NM_000102.3:c.1084C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Complete combined 17-alpha-hydroxylase/17,20-lyase deficiency
Identifiers:
MedGen: CN042980

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000022025OMIM
no assertion criteria provided
Pathogenic
(Apr 19, 2013)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

P450c17 deficiency in Brazilian patients: biochemical diagnosis through progesterone levels confirmed by CYP17 genotyping.

Martin RM, Lin CJ, Costa EM, de Oliveira ML, Carrilho A, Villar H, Longui CA, Mendonca BB.

J Clin Endocrinol Metab. 2003 Dec;88(12):5739-46.

PubMed [citation]
PMID:
14671162

Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency.

Costa-Santos M, Kater CE, Auchus RJ; Brazilian Congenital Adrenal Hyperplasia Multicenter Study Group..

J Clin Endocrinol Metab. 2004 Jan;89(1):49-60.

PubMed [citation]
PMID:
14715827

Details of each submission

From OMIM, SCV000022025.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In 3 affected members of a nonconsanguineous Brazilian family with combined 17-alpha-hydroxylase/17,20-lyase deficiency (202110), Martin et al. (2003) identified compound heterozygosity for mutations in the CYP17A1 gene: a 6535G-A transition in exon 6, resulting in an arg362-to-cys (R362C) substitution, and a 7564T-C transition in exon 7, resulting in a trp406-to-arg substitution (W406R; 609300.0024). In a note added in proof, the authors stated that both the R362C and W406R mutations independently result in functionally inactive proteins.

In a molecular genetic analysis of 24 subjects from 19 families with 17-hydroxylase deficiency in Brazil, Costa-Santos et al. (2004) found that the R362C mutation accounted for 32% of the mutant alleles. The R362C mutation was completely inactive when studied in COS-7 cells and yeast microsomes; however, phenotypic features varied among subjects. The authors found mutations R362C and W406R principally in families with Portuguese and Spanish ancestry, respectively, suggesting that 2 independent founder effects contribute to the increased prevalence of 17-hydroxylase deficiency in Brazil.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 1, 2015